Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment

This publication has 9 references indexed in Scilit:

• Hematopathologic and cytogenetic findings in imatinib mesylate–treated chronic myelogenous leukemia patients: 14 months' experience
  Blood, 2002
• Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8
  Leukemia, 2002
• The Biology of Chronic Myeloid Leukemia
  New England Journal of Medicine, 1999
• MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia
  Genes, Chromosomes and Cancer, 1999
• Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
  Proceedings of the National Academy of Sciences, 1990
• Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
  Science, 1990
• Translocation (2;11) (p21;q23) in acute non‐lymphocytic leukaemia: A non‐random association
  Scandinavian Journal of Haematology, 1986
• Confirming evidence for the clonal development and stem cell origin of philadelphia chromosome-negative chronic myelogenous leukemia
  American Journal of Hematology, 1984
• Evidence for a multistep pathogenesis of chronic myelogenous leukemia
  Blood, 1981